Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
about
Interventions for enhancing medication adherenceInterventions for enhancing medication adherenceMometasone furoate in the management of asthma: a reviewMometasone furoate nasal spray: a systematic reviewLong-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.Mometasone furoate dry powder inhaler for the treatment of asthma.Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trialFluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthmaOnce-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation.Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary dThe efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.One-year treatment with mometasone furoate in chronic obstructive pulmonary diseaseTiming Matters: Circadian Rhythm in Sepsis, Obstructive Lung Disease, Obstructive Sleep Apnea, and Cancer.Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma.Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children.A systematic review of adverse drug events associated with administration of common asthma medications in children.The health-related quality of life effects of once-daily cetirizine HCl syrup in children with seasonal allergic rhinitis.Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach.Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
P2860
Q24187912-7D6718AE-0643-49F8-95DB-97F394488E6AQ24243296-19ECAE08-D51D-4CB2-83F8-53B31F315064Q24652990-338696B5-3A80-46FD-A7B9-6A8A3B4DA3CEQ26747719-18E59E26-FD15-4013-9535-54A989B913C9Q33481321-B8C0E6BA-D137-43DC-8FD3-CD0A26C3480DQ33522061-060F9540-504C-4735-B975-6CE9D9A0DDFEQ34633474-7B522403-AFF8-4403-AC1C-9965A73555D9Q35065270-66E241A2-6C8C-47AA-8597-8B78D7C090E7Q35554841-6F0C2C58-EB60-48BB-9485-524056477E43Q35766467-945FB374-D32E-414B-8500-6C378F7C4B24Q36005008-DE045340-3B82-403A-BB67-0CC8766DE909Q36679740-99A719F3-AA06-4968-9B2F-39CB4D4BBAA3Q36684524-0FD95817-A01D-4C42-AD01-3221B875B93FQ37101342-F16ADA77-3880-444E-8B23-634684F2EDB4Q37241660-DA34040A-1956-49A8-BC8B-D531414A551EQ37313138-1F8B444B-3F5D-47A9-972F-2D593650A4BEQ37556510-327A99C4-11EF-4B9C-9C40-748FEF7AA715Q38632045-C6C14524-3E47-408F-8849-6882CC1BD1F0Q39400505-A0CA35FA-20E7-4FEA-8089-86AD5E495595Q42603944-30A8104C-D612-4C8E-BBA1-3BD8281B13A5Q46410562-9AFF6D27-1CCA-4B39-9539-E7B8F1CE869AQ46786774-F67671CF-F94A-4721-AD5D-4695655EE8B2Q48943114-19660905-9184-4E29-B91D-D390D0D816FAQ50247636-15731044-E961-4C70-8CD1-0CCFDBA7A552
P2860
Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Comparison of once-daily to tw ...... ne furoate dry powder inhaler.
@ast
Comparison of once-daily to tw ...... ne furoate dry powder inhaler.
@en
type
label
Comparison of once-daily to tw ...... ne furoate dry powder inhaler.
@ast
Comparison of once-daily to tw ...... ne furoate dry powder inhaler.
@en
prefLabel
Comparison of once-daily to tw ...... ne furoate dry powder inhaler.
@ast
Comparison of once-daily to tw ...... ne furoate dry powder inhaler.
@en
P2093
P1476
Comparison of once-daily to tw ...... ne furoate dry powder inhaler.
@en
P2093
Ramsdell JW
P356
10.1016/S1081-1206(10)62353-8
P577
2001-01-01T00:00:00Z